Lower risks of new-onset acute pancreatitis and pancreatic cancer in sodium glucose cotransporter 2 (SGLT2) inhibitors compared to dipeptidyl peptidase-4 (DPP4) inhibitors: A propensity score-matched study with competing risk analysis
Journal article
Tse, G. 2023. Lower risks of new-onset acute pancreatitis and pancreatic cancer in sodium glucose cotransporter 2 (SGLT2) inhibitors compared to dipeptidyl peptidase-4 (DPP4) inhibitors: A propensity score-matched study with competing risk analysis. Diabetes Epidemiology and Management. 9, p. 100115. https://doi.org/10.1016/j.deman.2022.100115
| Authors | Tse, G. |
|---|---|
| Abstract | Background Methods Results Conclusions |
| Keywords | Pancreatitis; Pancreatic cancer; Sodium glucose cotransporter 2 (SGLT2) inhibitors; Dipeptidyl peptidase-4 (DPP4) inhibitors |
| Year | 2023 |
| Journal | Diabetes Epidemiology and Management |
| Journal citation | 9, p. 100115 |
| Publisher | Elsevier |
| ISSN | 2666-9706 |
| Digital Object Identifier (DOI) | https://doi.org/10.1016/j.deman.2022.100115 |
| Official URL | https://www.sciencedirect.com/science/article/pii/S2666970622000658 |
| Publication dates | |
| Online | 23 Nov 2022 |
| Publication process dates | |
| Accepted | 27 Oct 2022 |
| Deposited | 19 May 2023 |
| Publisher's version | License |
| Output status | Published |
https://repository.canterbury.ac.uk/item/949q3/lower-risks-of-new-onset-acute-pancreatitis-and-pancreatic-cancer-in-sodium-glucose-cotransporter-2-sglt2-inhibitors-compared-to-dipeptidyl-peptidase-4-dpp4-inhibitors-a-propensity-score-matched
Download files
209
total views61
total downloads0
views this month0
downloads this month